Biocryst Pharmaceuticals (BCRX) Change in Inventory (2010 - 2026)

Biocryst Pharmaceuticals has reported Change in Inventory for 13 years, with the latest figure at $4.8 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Inventory rose 457.13% year-over-year to $4.8 million; the trailing twelve-month figure through Mar 2026 stood at $5.6 million (up 47.25% YoY), and the FY2025 full-year result was $1.6 million, down 60.64% from the prior year.
• Change in Inventory for Q1 2026 stood at $4.8 million, up from $515000.0 in the prior quarter.
• The five-year high for Change in Inventory was $7.2 million in Q2 2022, with the low at -$1.4 million in Q2 2025.
• Historically, Change in Inventory has averaged $1.4 million across 5 years, with a median of $1.2 million in 2022.
• Annual changes were most pronounced in 2023 — Change in Inventory sank 178.19% — and 2024, when it soared 1031.3%.
• Biocryst Pharmaceuticals' Change in Inventory stood at $1.2 million in 2022, then tumbled by 178.19% to -$907000.0 in 2023, then surged by 338.48% to $2.2 million in 2024, then tumbled by 76.19% to $515000.0 in 2025, then surged by 841.17% to $4.8 million in 2026.
• The last three Change in Inventory figures came in at $4.8 million (Q1 2026), $515000.0 (Q4 2025), and $1.7 million (Q3 2025), per Business Quant data.